Dogan Ciloglu | Tuberculosis | Best Review Article Award

Best Review Article Award

Dogan Ciloglu
Ataturk University, Turkey
Researcher Information
Affiliation Ataturk University
Country Turkey
Scopus ID 22833389400
Documents 16
Citations 425
h-index 8
Subject Area Tuberculosis
Event International Research Awards on Infectious Diseases

The Best Review Article Award recognizes scholarly contributions that demonstrate methodological clarity, analytical depth, and substantial relevance to contemporary scientific research. Dogan Ciloglu of Ataturk University has contributed to the field of tuberculosis-related infectious disease research through publications indexed in international academic databases and through participation in scientific communication initiatives associated with infectious disease studies.[1] The recognition framework associated with the International Research Awards on Infectious Diseases highlights the importance of review-based scientific synthesis, interdisciplinary knowledge integration, and evidence-oriented academic discourse.[1]

Abstract

This academic recognition article documents the scholarly profile and research-oriented contributions of Dogan Ciloglu in relation to the Best Review Article Award associated with the International Research Awards on Infectious Diseases. The article outlines bibliometric indicators, thematic specialization in tuberculosis research, and the broader significance of review-based scientific communication within infectious disease scholarship. Emphasis is placed on publication visibility, citation-based academic influence, and the role of systematic literature interpretation in supporting evidence-based healthcare research.[1]

Keywords

Tuberculosis, Infectious Diseases, Review Article Award, Academic Recognition, Scopus Author Profile, Citation Analysis, Evidence-Based Medicine, Research Publications, Scholarly Communication, Infectious Disease Research

Introduction

Review articles constitute an important component of scientific literature because they summarize emerging evidence, identify methodological limitations, and facilitate interdisciplinary interpretation of research findings. Within the field of infectious diseases, review-based publications are especially relevant due to the rapid evolution of diagnostic technologies, antimicrobial resistance patterns, and global disease surveillance systems.[1]

Tuberculosis remains a major public health challenge with significant clinical, epidemiological, and socio-economic implications worldwide. Academic contributions that improve understanding of tuberculosis through comprehensive literature evaluation contribute to evidence-based policymaking and clinical awareness.[1]The Best Review Article Award acknowledges scholarly efforts that support scientific advancement through analytical synthesis and publication quality.

Research Profile

Dogan Ciloglu is affiliated with Ataturk University in Turkey and has an indexed research profile associated with infectious disease and tuberculosis-related investigations. According to publicly available Scopus metrics, the researcher has produced sixteen indexed documents with a citation count exceeding four hundred citations and an h-index of eight.[1]

The research portfolio demonstrates participation in scholarly publication activities connected to infectious disease monitoring, review methodologies, and clinical interpretation of scientific findings. Bibliometric indicators such as citation frequency and h-index are commonly used to evaluate academic visibility and sustained scholarly engagement within scientific communities.[1]

Research Contributions

The scholarly contributions associated with Dogan Ciloglu emphasize infectious disease research with relevance to tuberculosis and evidence-oriented clinical interpretation. Review-based investigations contribute to scientific progress by consolidating fragmented research outcomes into coherent analytical frameworks.[1]

  • Contribution to literature synthesis in infectious disease research.
  • Support for evidence-based evaluation of tuberculosis-related studies.
  • Participation in internationally indexed academic publishing.
  • Integration of clinical and epidemiological perspectives in scientific interpretation.
  • Enhancement of scholarly communication through review-oriented publications.

Publications

Representative scholarly outputs and indexed publication activities associated with the researcher reflect ongoing engagement in infectious disease scholarship and academic review methodologies.[1]

  1. Research publications indexed in Scopus under Author ID 22833389400.
  2. Tuberculosis-related review and infectious disease interpretation studies.
  3. Scholarly contributions relevant to clinical infectious disease communication.
  4. Collaborative scientific outputs supporting evidence synthesis approaches.

Research Impact

Research impact within academic environments is frequently evaluated using citation metrics, publication indexing, and scholarly visibility indicators. The citation profile associated with Dogan Ciloglu suggests that the published research has contributed to ongoing academic discussions within infectious disease literature.[1]

Review-oriented publications are particularly influential because they enable researchers, clinicians, and policy analysts to interpret evolving scientific evidence in a consolidated format. Such publications may facilitate improved understanding of disease epidemiology, therapeutic strategies, and public health responses.

Award Suitability

The Best Review Article Award is intended to recognize academic contributions that demonstrate clarity of interpretation, methodological consistency, and scientific relevance. The bibliometric profile and publication activity associated with Dogan Ciloglu indicate alignment with these objectives through contributions to infectious disease scholarship and literature synthesis.[1]

  • Indexed research visibility through Scopus documentation.
  • Citation-based evidence of scholarly engagement.
  • Thematic specialization in infectious disease and tuberculosis research.
  • Contribution to evidence-based scientific interpretation.
  • Academic relevance to review-oriented publication standards.

Conclusion

The academic profile of Dogan Ciloglu reflects sustained engagement in infectious disease scholarship and review-based scientific communication. Through indexed publications, citation impact, and subject specialization in tuberculosis, the researcher demonstrates characteristics associated with scholarly recognition frameworks such as the Best Review Article Award. The International Research Awards on Infectious Diseases continue to encourage analytical scientific contributions that support evidence-driven healthcare knowledge and interdisciplinary research development.[1]

References

    1. Elsevier. (n.d.). Scopus author details: Dogan Ciloglu, Author ID 22833389400. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=22833389400
    2. Grant, M. J., & Booth, A. (2009). A typology of reviews: An analysis of 14 review types and associated methodologies.
      https://doi.org/10.1111/j.1471-1842.2009.00848.x

Prof. Zhongde Zhang | Infectious Diseases Prevention | Best Researcher Award

Prof. Zhongde Zhang | Infectious Diseases Prevention | Best Researcher Award

Guangzhou University of Chinese Medicine| China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Professor Zhongde Zhang embarked on his academic journey with a profound focus on Traditional Chinese Medicine (TCM). His foundational studies at prestigious institutions in China enabled him to master both the theoretical and practical aspects of TCM, paving the way for his expertise in addressing complex health challenges, particularly in infectious disease prevention.

💼PROFESSIONAL ENDEAVORS

As the President of Guangdong Provincial Hospital of Traditional Chinese Medicine and Vice-President of Guangzhou University of Traditional Chinese Medicine, Professor Zhang has played a pivotal role in advancing TCM’s integration into modern medical systems. His leadership has elevated both institutions into centers of excellence, emphasizing research, education, and patient-centered care.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES PREVENTION

Professor Zhang’s contributions to infectious diseases prevention are revolutionary. His research emphasizes the synergistic potential of TCM and modern medicine in addressing respiratory diseases and other intractable illnesses. His groundbreaking approaches include developing TCM-based immune therapies, advancing the understanding of pathogenesis, and creating integrative treatment protocols.

🌍IMPACT AND INFLUENCE

Professor Zhang’s influence transcends national boundaries. His advocacy for the integration of Traditional and Modern Medicine in global health policies has positioned him as a global health advocate. His efforts in addressing antibiotic resistance, pandemics, and chronic respiratory diseases have significantly improved public health outcomes and reinforced TCM’s role in international health systems.

📚ACADEMIC CITES

With a prolific record of peer-reviewed publications, Professor Zhang’s research is widely recognized and frequently cited in international journals. His work has provided a robust evidence base for TCM applications in infectious disease prevention and treatment, further bridging the gap between Eastern and Western medicine.

🏆RESEARCH GRANTS AND FUNDING

Professor Zhang has successfully led projects under the Ministry of Science and Technology’s major research and development program and secured multiple National Natural Science Foundation grants. These prestigious grants have fueled innovative studies on infectious diseases, respiratory illnesses, and immune system modulation, strengthening his position as a leading researcher in TCM.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Professor Zhang’s legacy lies in his vision for the future of healthcare, where TCM seamlessly integrates with modern medical advancements. His commitment to mentorship, innovative research, and developing global collaborations ensures a lasting impact on medical science and infectious disease prevention.

🌟A VISIONARY IN INFECTIOUS DISEASES

Recognized as a National Famous TCM Scholar, Professor Zhang embodies the spirit of innovation and collaboration. His visionary leadership has redefined the role of TCM in preventing and managing infectious diseases, marking him as a trailblazer in this field.

📑NOTABLE PUBLICATIONS 

“Fuzheng Jiedu decoction alleviates H1N1 virus-induced acute lung injury in mice by suppressing the NLRP3 inflammasome activation”

Authors: Li, Y., Zou, H., Ma, L., …, Li, G., Zhang, Z.
Publication Year: 2025
Journal: Journal of Ethnopharmacology

” Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization”

Authors: Liao, R., Sun, Z.-C., Wang, L., …, Wu, J., Zhang, Z.
Publication Year: 2025
Journal: Bioactive Materials

“Efficacy and safety of integrated traditional Chinese and Western medicine for rheumatoid arthritis-interstitial lung disease: A systematic review and meta-analysis”

Authors: Lu, P., Li, L., Liu, B., …, Zhang, Z., Lu, C.
Publication Year: 2024
Journal: Heliyon

“Natural pachypodol integrated, lung targeted and inhaled lipid nanomedicine ameliorates acute lung injury via anti-inflammation and repairing lung barrier”

Authors: Sun, Z.-C., Liao, R., Xian, C., …, Liu, Y., Wu, J.
Publication Year: 2024
Journal: Journal of Controlled Release

“Mendelian randomization and Bayesian model averaging of autoimmune diseases and Long COVID”

Authors: Feng, J., Chen, J., Li, X., …, Lu, Y., Liu, Y.
Publication Year: 2024
Journal: Frontiers in Genetics